Literature DB >> 33420897

Resected WHO grade I meningioma and predictors of local control.

Kamila Nowak-Choi1, Joshua D Palmer2, James Casey3, Ameet Chitale3, Ingrid Kalchman4, Elizabeth Buss4, Scott W Keith5, Sarah E Hegarty5, Mark Curtis6, Charalambos Solomides6, Wenyin Shi7, Kevin Judy3, David W Andrews3, Christopher Farrell3, Maria Werner-Wasik7.   

Abstract

INTRODUCTION: Despite optimal surgical resection, meningiomas may recur, with increasing grade and the degree of resection being predictive of risk. We hypothesize that an increasing Ki67 correlates with a higher risk of recurrence of resected WHO grade I meningiomas.
METHODS: The study population consisted of patients with resected WHO grade 1 meningiomas in locations outside of the base of skull. Digitally scanned slides stained for Ki67 were analyzed using automatic image analysis software in a standardized fashion.
RESULTS: Recurrence was observed in 53 (17.7%) of cases with a median follow up time of 25.8 months. Ki67 ranged from 0 to 30%. Median Ki67 was 5.1% for patients with recurrence and 3.5% for patients without recurrence. In unadjusted analyses, high Ki-67 (≥ 5 vs. < 5) vs. ≥ 5) was associated with over a twofold increased risk of recurrence (13.1% vs. 27% respectively; HR 2.1731; 95% CI [1.2534, 3.764]; p = 0.006). After Adjusting for patient or tumor characteristics, elevated Ki-67 remained significantly correlated with recurrence. Grade 4 Simpson resection was noted in 71 (23.7%) of patients and it was associated with a significantly increased risk of recurrence (HR 2.56; 95% CI [1.41, 4.6364]; p = 0.002).
CONCLUSIONS: WHO grade 1 meningiomas exhibit a significant rate of recurrence following resection. While Ki-67 is not part of the WHO grading criteria of meningiomas, a value greater than 5% is an independent predictor for increased risk of local recurrence following surgical resection.

Entities:  

Keywords:  Extent of resection; Ki-67; Radiation treatment; Recurrence risk; WHO grade I meningioma

Year:  2021        PMID: 33420897     DOI: 10.1007/s11060-020-03688-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  15 in total

1.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  D SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

Review 2.  Histological classification and molecular genetics of meningiomas.

Authors:  Markus J Riemenschneider; Arie Perry; Guido Reifenberger
Journal:  Lancet Neurol       Date:  2006-12       Impact factor: 44.182

3.  Re-Evaluating Simpson Grade I, II, and III Resections in Neurosurgical Treatment of World Health Organization Grade I Meningiomas.

Authors:  Alvaro Otero-Rodriguez; Maria Dolores Tabernero; Maria Cristina Munoz-Martin; Pablo Sousa; Alberto Orfao; Daniel Pascual-Argente; Maria Gonzalez-Tablas; Laura Ruiz-Martin
Journal:  World Neurosurg       Date:  2016-09-13       Impact factor: 2.104

4.  Response criteria for phase II studies of supratentorial malignant glioma.

Authors:  D R Macdonald; T L Cascino; S C Schold; J G Cairncross
Journal:  J Clin Oncol       Date:  1990-07       Impact factor: 44.544

5.  Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.

Authors:  Soichi Oya; Kensuke Kawai; Hirofumi Nakatomi; Nobuhito Saito
Journal:  J Neurosurg       Date:  2012-05-04       Impact factor: 5.115

6.  The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study.

Authors:  Ellen Abry; Ingrid Ø Thomassen; Øyvind O Salvesen; Sverre H Torp
Journal:  Pathol Res Pract       Date:  2010-10-15       Impact factor: 3.250

7.  Skull base meningiomas: Long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT).

Authors:  Stephanie E Combs; Sebastian Adeberg; Jan-Oliver Dittmar; Thomas Welzel; Stefan Rieken; Daniel Habermehl; Peter E Huber; Jürgen Debus
Journal:  Radiother Oncol       Date:  2012-08-18       Impact factor: 6.280

8.  MIB-1 immunolabeling: a valuable marker in prediction of benign recurring meningiomas.

Authors:  Mahesha Vankalakunti; Rakesh Kumar Vasishta; Bishan Das Radotra; Virender Kumar Khosla
Journal:  Neuropathology       Date:  2007-10       Impact factor: 1.906

Review 9.  Epidemiology and etiology of meningioma.

Authors:  Joseph Wiemels; Margaret Wrensch; Elizabeth B Claus
Journal:  J Neurooncol       Date:  2010-09-07       Impact factor: 4.130

10.  A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.

Authors:  Arvydas Laurinavicius; Benoit Plancoulaine; Aida Laurinaviciene; Paulette Herlin; Raimundas Meskauskas; Indra Baltrusaityte; Justinas Besusparis; Darius Dasevicius; Nicolas Elie; Yasir Iqbal; Catherine Bor
Journal:  Breast Cancer Res       Date:  2014       Impact factor: 6.466

View more
  3 in total

1.  Efficient Prediction of Ki-67 Proliferation Index in Meningiomas on MRI: From Traditional Radiological Findings to a Machine Learning Approach.

Authors:  Yanjie Zhao; Jianfeng Xu; Boran Chen; Le Cao; Chaoyue Chen
Journal:  Cancers (Basel)       Date:  2022-07-26       Impact factor: 6.575

2.  Machine Learning Using Multiparametric Magnetic Resonance Imaging Radiomic Feature Analysis to Predict Ki-67 in World Health Organization Grade I Meningiomas.

Authors:  Omaditya Khanna; Anahita Fathi Kazerooni; Christopher J Farrell; Michael P Baldassari; Tyler D Alexander; Michael Karsy; Benjamin A Greenberger; Jose A Garcia; Chiharu Sako; James J Evans; Kevin D Judy; David W Andrews; Adam E Flanders; Ashwini D Sharan; Adam P Dicker; Wenyin Shi; Christos Davatzikos
Journal:  Neurosurgery       Date:  2021-10-13       Impact factor: 5.315

3.  The applicability of established clinical and histopathological risk factors for tumor recurrence during long-term postoperative care in meningioma patients.

Authors:  Swenja Lüthge; Dorothee Cäcilia Spille; Andrea Ulrike Steinbicker; Stephanie Schipmann; Eileen Maria Susanne Streckert; Katharina Hess; Oliver Martin Grauer; Werner Paulus; Walter Stummer; Benjamin Brokinkel
Journal:  Neurosurg Rev       Date:  2021-11-20       Impact factor: 3.042

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.